Over half of the world’s population is in Asia. It’s well known that different diseases hit certain races or ethnicities harder than others. I’ve got a hand ligament contracture that dominantly it’s Northern Europeans. I cannot fault her one bit for her valid observation:
“We know that there are genetic and ethnic differences in the way we respond to drugs and in the way drug doses are arrived at. I think people now recognize that this [research on Asian populations] is valuable data. If you really want to build value through innovation, then this kind of differentiated data is going to be very powerful.”
It is not a “dig” against Caucasians.
“Caucasians” are the instant market. The most profitable. That’s why trials are directed towards them.
And, as another said, Indians are not distinct from Caucasians. Though perhaps more representative of the Asian population.